Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Incarceration Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Incarceration. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Incarceration clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 4 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by University of California, Los Angeles (1), University of Thessaly (1), Lifespan (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Mobile Enhanced Prevention Support (MEPS) (behavioral, 1 trial), followed by Control, Sofosbuvir / Velpatasvir Oral Tablet [Epclusa].

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Incarceration trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07433985

California MEPS Hub

The California Hub for HIV/SUD Prevention Research with Reentry Populations addresses the question: "Can the evidence-based MEPS intervention be adapted and implemented at a range...

Sponsor: University of California, Los AngelesEnrolling: 3183 locations
RECRUITINGNCT07558187

Systematic Examination of Health Inequalities: Documentation, Patterns, and Determinants

The existence of social inequalities is a major global issue and a salient challenge for the European Union. During COVID-19 pandemic, health disparities became more evident....

Sponsor: University of ThessalyEnrolling: 20005 locations
RECRUITINGPhase 4NCT06953479

Implementing Low-Barrier HCV Treatment in a Jail Setting

The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more...

Sponsor: LifespanEnrolling: 401 location

Frequently Asked Questions

There are currently 3 clinical trials for Incarceration, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Incarceration, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Incarceration, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.